1011.HK Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 03:39):

Stats
Today's Volume	717 500
Average Volume	8.42M
Market Cap	52.62M
EPS	HKD0 ( 2023-08-31 )
Last Dividend	HKD0.0350 ( 2018-07-10 )
Next Dividend	HKD0 ( N/A )
P/E	-1.050
ATR14	HKD0 (0.00%)

China NT Pharma Group Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China NT Pharma Group Financials

Annual	2022
Revenue:	HKD207.09M
Gross Profit:	HKD125.29M (60.50 %)
EPS:	HKD-0.0350

Q2	2023
Revenue:	HKD82.61M
Gross Profit:	HKD52.30M (63.31 %)
EPS:	HKD-0.00250

Q4	2022
Revenue:	HKD86.59M
Gross Profit:	HKD50.42M (58.22 %)
EPS:	HKD-0.0200

Q2	2022
Revenue:	HKD120.50M
Gross Profit:	HKD74.87M (62.13 %)
EPS:	HKD-0.0149

Financial Reports:

No articles found.

China NT Pharma Group Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China NT Pharma Group Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.934 - low (50.00%) | Divividend Growth Potential Score: 3.39 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0100	2016-05-31
Last Dividend	HKD0.0350	2018-07-10
Next Dividend	HKD0	N/A
Payout Date	2018-08-02
Next Payout Date	N/A
# dividends	3	--
Total Paid Out	HKD0.0700	--
Avg. Dividend % Per Year	0.00%	--
Score	1.33	--
Div. Sustainability Score	1.934
Div.Growth Potential Score	3.39
Div. Directional Score	2.66	--

Next Divdend (Est)
(2025-01-27)

HKD0 Estimate 0.00 %

Dividend Stability

0.02 Very Bad

Dividend Score

1.33

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
6198.HK	Ex Dividend Knight	2023-06-08	Annually	0.00%
1890.HK	Ex Dividend Knight	2023-08-04	Annually	0.00%
0916.HK	Ex Dividend Junior	2023-06-20	Annually	0.00%
0052.HK	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
2866.HK	Ex Dividend Junior	2023-07-06	Sporadic	0.00%
1461.HK	Ex Dividend Junior	2023-06-20	Sporadic	0.00%
0543.HK	No Dividend Player	2023-05-17	Annually	0.00%
6969.HK	Ex Dividend Junior	2023-09-06	Semi-Annually	0.00%
1988.HK	Ex Dividend Junior	2023-06-13	Annually	0.00%
1066.HK	Ex Dividend Knight	2023-10-19	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.259	1.500	-5.17	-7.76	[0 - 0.5]
returnOnAssetsTTM	-0.0415	1.200	-1.383	-1.659	[0 - 0.3]
returnOnEquityTTM	0.179	1.500	9.12	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0906	0.800	-4.55	-3.64	[1 - 3]
quickRatioTTM	0.0805	0.800	-4.23	-3.39	[0.8 - 2.5]
cashRatioTTM	0.00986	1.500	-1.056	-1.584	[0.2 - 2]
debtRatioTTM	0.808	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0103	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.00837	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	-3.44	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.607	1.000	3.22	3.22	[0.2 - 0.8]
operatingProfitMarginTTM	0.148	1.000	9.04	9.04	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0271	1.000	-0.960	-0.960	[0.2 - 2]
assetTurnoverTTM	0.160	0.800	-2.26	-1.812	[0.5 - 2]
Total Score				1.934

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.069	1.000	-0.209	0	[1 - 100]
returnOnEquityTTM	0.179	2.50	9.44	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.00837	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0103	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.137	1.000	9.08	0	[0.1 - 0.5]
Total Score				3.39

China NT Pharma Group

China NT Pharma Group Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, sales, and distribution of pharmaceutical products in the People's Republic of China and internationally. It manufactures, sells, and trades in prescription medicines for the tumor and blood system diseases, digestive system diseases, central nervous system diseases, diseases of respiratory system, and other therapeutic fields; and produces and sells NT branded products and generic drugs. The company also provides marketing and promotion services to suppliers, and logistics and consulting services. China NT Pharma Group Company Limited was founded in 1995 and is headquartered in Suzhou, the People's Republic of China.